These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1343687)

  • 21. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission-blocking immunity against malaria and other vector-borne diseases.
    Kaslow DC
    Curr Opin Immunol; 1993 Aug; 5(4):557-65. PubMed ID: 8216932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.
    Radtke AJ; Anderson CF; Riteau N; Rausch K; Scaria P; Kelnhofer ER; Howard RF; Sher A; Germain RN; Duffy P
    Sci Rep; 2017 Jan; 7():40312. PubMed ID: 28091576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies.
    Stowers AW; Keister DB; Muratova O; Kaslow DC
    Infect Immun; 2000 Oct; 68(10):5530-8. PubMed ID: 10992450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pfs230: from malaria transmission-blocking vaccine candidate toward function.
    Williamson KC
    Parasite Immunol; 2003 Jul; 25(7):351-9. PubMed ID: 14521577
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.
    Wizel B; Kumar N
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9533-7. PubMed ID: 1719534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli.
    Milek RL; Roeffen WF; Kocken CH; Jansen J; Kaan AM; Eling WM; Sauerwein RW; Konings RN
    Parasite Immunol; 1998 Aug; 20(8):377-85. PubMed ID: 9767603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
    Farrance CE; Chichester JA; Musiychuk K; Shamloul M; Rhee A; Manceva SD; Jones RM; Mamedov T; Sharma S; Mett V; Streatfield SJ; Roeffen W; van de Vegte-Bolmer M; Sauerwein RW; Wu Y; Muratova O; Miller L; Duffy P; Sinden R; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():191-8. PubMed ID: 21266847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen.
    Mlambo G; Kumar N; Yoshida S
    Vaccine; 2010 Oct; 28(43):7025-9. PubMed ID: 20709008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.
    McGuire KA; Miura K; Wiethoff CM; Williamson KC
    Malar J; 2017 Jun; 16(1):254. PubMed ID: 28619071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of humoral immune response in mammals immunized with Plasmodium falciparum antigenic preparations.
    Cubas AB; Cunha F; Nitcheu IK; Rolland L; Ciceron L; Carvalho AB; Furtado AF; Monjour L
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():429-34. PubMed ID: 1343723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.
    Duffy PE; Kaslow DC
    Infect Immun; 1997 Mar; 65(3):1109-13. PubMed ID: 9038325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate.
    Gozar MM; Muratova O; Keister DB; Kensil CR; Price VL; Kaslow DC
    Exp Parasitol; 2001 Feb; 97(2):61-9. PubMed ID: 11281702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Singh SK; Thrane S; Chourasia BK; Teelen K; Graumans W; Stoter R; van Gemert GJ; van de Vegte-Bolmer MG; Nielsen MA; Salanti A; Sander AF; Sauerwein RW; Jore MM; Theisen M
    Front Immunol; 2019; 10():1256. PubMed ID: 31231386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35.
    Kalra A; Edula JR; Gupta PK; Pandey AK; Chauhan VS
    PLoS One; 2016; 11(10):e0165720. PubMed ID: 27798691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmonella flagellin acted as an effective fusion partner for expression of Plasmodium falciparum surface protein 25 in Escherichia coli.
    Qian F; Li M; Chen Y; Jiang L; Xu H
    Hum Vaccin Immunother; 2016 Sep; 12(9):2362-4. PubMed ID: 27058511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.